Abstract:The establishment of a compliant radiopharmacy facility within a university setting is crucial for supporting fundamental and preclinical studies, as well as for the production of high-quality radiopharmaceuticals for clinical testing in human protocols as part of Investigational New Drug (IND) applications that are reviewed and approved by the U.S. Food and Drug Administration (FDA). This manuscript details the design and construction of a 550 ft2 facility, which included a radiopharmacy and a radiochemistry laboratory, to support radiopharmaceutical development research and facilitate translational research projects. The facility was designed to meet FDA guidelines for the production of aseptic radiopharmaceuticals in accordance with current good manufacturing practice (cGMP). A modular hard-panel cleanroom was constructed to meet manufacturing classifications set by the International Organization of Standardization (ISO), complete with a gowning room and an anteroom. Two lead-shielded hot cells and two dual-mini hot cells, connected via underground trenches containing shielded conduits, were installed to optimize radioactive material transfer while minimizing personnel radiation exposure. Concrete blocks and lead bricks provided sufficient and cost-effective radiation shielding for the trenches. Air quality was controlled using pre-filters and high-efficiency particulate air (HEPA) filters to meet cleanroom ISO7 (Class 10,000) standards. A laminar-flow biosafety cabinet was installed in the cleanroom for preparation of sterile dose vials. Noteworthy was a laminar-flow insert in the hot cell that provided a shielded laminar-flow sterile environment meeting ISO5 (class 100) standards. The design included the constant control and monitoring of differential air pressures across the cleanroom, anteroom, gowning room, and controlled research space, as well as maintenance of temperature and humidity. The facility was equipped with state-of-the-art equipment for quality control and release testing of radiopharmaceuticals. Administrative controls and standard operating procedures (SOPs) were established to ensure compliance with manufacturing standards and regulatory requirements. Overall, the design and construction of this radiopharmacy facility exemplified a commitment to advancing fundamental, translational, and clinical applications of radiopharmaceutical research within an academic environment.

Building used by Marie Curie will be dismantled to erect cancer centre

France digs deep for nuclear waste

Row over Curie building ends on a high note

The visual diplomacy of cancer treatments: the mediatic legacy of the Curies in the early transnational fight against cancer

Marie Curie (1867-1934): Twice Nobel Laureate and Her Enduring Legacy in Radiation Medicine

Historical monuments and lead pollution: Lessons from the case of Notre-Dame de Paris and Sainte-Chapelle

Advances in Technology and Process in the Spent Fuel Reprocessing Operations in France

Rejets en mer des eaux résiduaires faiblemhent radioactives du centre de la Hague

Supporting companies dealing with asbestos risk: Practical tools for occupational health services, risk prevention specialists, and companies

Quelle place pour les arcs électriques et les réacteurs plasmas dans l'" Inventaire et valorisation des collections, archives scientifiques et biens culturels " de l'université de Limoges ?

Decommissioning of a Medical Cyclotron Vault: the Case Study of the National Cancer Institute of Milano

Bayesian identification and estimation of radon-related increased hazard rates of cancer death in the updated French cohort of uranium miners (1946–2014)

The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015

Design and Construction of a Radiochemistry Laboratory and cGMP-Compliant Radiopharmacy Facility

CA’REDIVIVUS: PRESERVATION OF HISTORIC REINFORCED CONCRETE HOUSING BUILDINGS IN EUROPE

When citizen science meets radon building diagnosis: Synthesis of a French pilot project developed in the framework of the European RadoNorm research project

Preparation for dismantling the liquid waste disposal system of MR and RFT research reactors

[Architecture, budget and dignity]

French contribution to develop Prussian blue

Fire risk analysis in ITER tritium building

The Planning and Design of a New PET Radiochemistry Facility